Prospect Financial Group LLC

Position in JNJ — Johnson & Johnson

CIK 2021762 ARLINGTON, VA

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$595,305

+$39,449 QoQ

Shares Held

2,344

+3.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.36%

of 13F equity value

Holder Rank

#3,539

of 4,676 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prospect Financial Group LLC holds $2,219,700 across 5 Drug Manufacturers - General names. JNJ ranks #2 (26.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	542	$650,091
2	JNJ	Johnson & Johnson This page	2,344	$595,305
3	MRK	Merck & Co., Inc.	2,699	$346,821
4	NVS	Novartis AG	2,175	$340,866
5	ABBV	AbbVie Inc.	1,139	$286,617

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$595,305	2,344	+3.1%	Shares	Sole	2026-08-07
2026-03-31	$555,856	2,274	-0.6%	Shares	Sole	2026-05-06
2025-12-31	$473,501	2,288	-3.9%	Shares	Sole	2026-02-10
2025-09-30	$441,485	2,381	+1.3%	Shares	Sole	2025-11-06
2025-06-30	$359,115	2,351	-12.1%	Shares	Sole	2025-08-07
2025-03-31	$443,622	2,675	-5.5%	Shares	Sole	2025-05-07
2024-12-31	$409,274	2,830	—	Shares	Sole	2025-02-11
No filing history on record for this holder in this stock.